500
Participants
Start Date
October 15, 2021
Primary Completion Date
February 1, 2022
Study Completion Date
March 15, 2022
Naïve patients - ACO therapy
Naïve patients will receive classic triple therapy (amoxicillin, clarithromycin and lansoprazole) for 14 days
Naïve patients - LNDL therapy
Naïve patients will receive Levofloxacin, nitazoxanide, doxycycline and Lansoprazole for 14 days
Naïve patients - MNDL therapy
Naïve patients will receive Moxifloxacin, nitazoxanide, doxycycline and Lansoprazole for 14 days
Treatment-experienced patients- LNDL therapy
Experienced patients will receive Levofloxacin, nitazoxanide, doxycycline and Lansoprazole for 14 days
Treatment-experienced patients- MNDL therapy
Experienced patients will receive Moxifloxacin, nitazoxanide, doxycycline and Lansoprazole for 14 days
RECRUITING
National Liver institute - Menoufia University, Shibīn al Kawm
Collaborators (1)
Future pharmaceutical industries
UNKNOWN
National Liver Institute, Egypt
OTHER